Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Cincinnati › NPI 1780633289
Supplier

Christ Hospital

Christ Hospital was paid $49.68M by Medicaid between Jan 2018 and Dec 2024, across 459 billing codes. Its largest line is 99283, emergency room visit (moderate) — 13% of everything it billed.

33Billing provider infoCHRIST HOSPITAL
CINCINNATI, OH 45219
33aNPI1780633289assigned 05/10/2006
33bProvider typePharmacy
28Total paid$49.68M
24GClaims1,766,522
24DCodes billed459
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pharmacy providers in Ohio

Rank by total paid#1 of 47
Median peer was paid$489.48
This provider vs. median101,502×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018162,626$3.49M
2019154,550$3.45M
2020136,604$4.00M
2021176,659$5.28M
2022189,994$5.45M
2023513,627$16.14M
2024incomplete432,462$11.86M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 13% 55,821 50,471 $6.51M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 13% 48,629 42,607 $6.39M
96361 Intravenous infusion, hydration; each additional hour 10% 18,200 14,840 $5.02M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.4% 21,061 17,887 $3.17M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 5.2% 32,293 24,605 $2.58M
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.2% 15,930 14,695 $1.61M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.2% 25,409 8,647 $1.59M
74176 Computed tomography, abdomen and pelvis; without contrast material 2.4% 4,251 3,580 $1.21M
70450 Computed tomography, head or brain; without contrast material 2.1% 4,795 4,025 $1.03M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.9% 3,290 2,672 $962K
80053 Comprehensive metabolic panel 1.4% 76,654 62,652 $705K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.3% 4,716 2,769 $665K
447 more codes
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.2% 22,147 $574K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 22,248 $467K
G0378 Hospital observation service, per hour <1% 6,138 $420K
95811 <1% 729 $418K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,769 $416K
80061 Lipid panel <1% 22,266 $368K
84443 Thyroid stimulating hormone (TSH) <1% 22,664 $350K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,213 $341K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,341 $336K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 3,284 $330K
36415 Collection of venous blood by venipuncture <1% 178,079 $320K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 2,653 $316K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,737 $304K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 2,413 $257K
C1776 Joint device (implantable) <1% 470 $256K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 398 $228K
80048 Basic metabolic panel (calcium, ionized) <1% 27,647 $226K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 983 $220K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 8,785 $215K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 12,737 $215K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 6,462 $211K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 88,494 $200K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 534 $192K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,555 $188K
85027 <1% 31,987 $183K
27447 <1% 60 $182K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 1,401 $177K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 5,805 $175K
62323 <1% 425 $163K
58661 <1% 145 $161K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 460 $159K
71046 Radiologic examination, chest; 2 views <1% 5,184 $158K
86780 <1% 9,007 $156K
83036 Hemoglobin; glycosylated (A1C) <1% 19,984 $148K
G0144 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision <1% 5,969 $140K
87800 <1% 3,012 $136K
86850 <1% 7,325 $134K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 729 $133K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 510 $130K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 6,636 $130K
59025 Fetal non-stress test <1% 862 $128K
97161 <1% 2,347 $126K
87086 Culture, bacterial; quantitative colony count, urine <1% 19,808 $126K
84484 <1% 33,656 $125K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 40,915 $124K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,674 $123K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 582 $117K
76642 <1% 1,094 $115K
27130 <1% 21 $106K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 3,715 $105K
86803 <1% 5,554 $105K
S9472 Cardiac rehabilitation program, non-physician provider, per diem <1% 1,673 $105K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 32,242 $103K
93356 <1% 521 $102K
83880 <1% 14,013 $101K
97162 <1% 1,845 $100K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 787 $99K
71250 <1% 1,018 $97K
71045 Radiologic examination, chest; single view <1% 25,225 $97K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 3,956 $96K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 797 $96K
76819 Fetal biophysical profile; without non-stress testing <1% 1,166 $95K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,500 $94K
82607 <1% 6,798 $93K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 2,864 $92K
78815 Positron emission tomography (PET) for limited area imaging <1% 183 $91K
80076 <1% 13,185 $91K
J0485 Injection, belatacept, 1 mg <1% 624 $89K
52000 <1% 142 $88K
70491 <1% 324 $88K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 4,022 $85K
96375 Therapeutic injection; each additional sequential IV push <1% 19,355 $85K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 358 $82K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 153 $82K
64483 <1% 187 $78K
93971 <1% 1,017 $78K
93308 <1% 432 $77K
76536 <1% 733 $74K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 472 $74K
93458 <1% 57 $68K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,661 $68K
87150 <1% 1,663 $64K
71271 <1% 430 $63K
82728 <1% 4,969 $61K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 633 $60K
80069 <1% 4,163 $59K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 3,794 $58K
93017 <1% 726 $57K
C1889 Implantable/insertable device, not otherwise classified <1% 657 $56K
76830 Ultrasound, transvaginal <1% 928 $54K
H2020 Therapeutic behavioral services, per diem <1% 332 $54K
82570 <1% 7,444 $52K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 674 $52K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,076 $52K
85610 <1% 21,290 $51K
72141 <1% 285 $50K
87481 <1% 2,580 $50K
93970 <1% 354 $50K
87340 <1% 4,841 $49K
86900 <1% 5,552 $48K
81025 <1% 36,801 $47K
93325 <1% 793 $47K
70486 <1% 590 $46K
72100 <1% 2,044 $46K
83550 <1% 5,858 $45K
84702 <1% 3,530 $44K
10060 <1% 274 $44K
84439 <1% 4,799 $44K
88307 <1% 630 $43K
76770 <1% 308 $43K
72131 <1% 530 $42K
83540 <1% 6,311 $41K
81003 <1% 30,040 $40K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 225 $39K
87511 <1% 2,558 $39K
86140 <1% 4,344 $37K
83735 <1% 16,298 $37K
97165 <1% 596 $36K
70496 <1% 157 $36K
86762 <1% 2,226 $35K
93925 <1% 340 $35K
83970 <1% 1,378 $35K
72125 Computed tomography, cervical spine; without contrast material <1% 877 $34K
64447 <1% 297 $34K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,578 $33K
73221 <1% 159 $33K
C9290 Injection, bupivacaine liposome, 1 mg <1% 467 $32K
00840 <1% 403 $32K
93351 <1% 117 $32K
76820 <1% 328 $32K
87077 <1% 4,343 $31K
J1756 Injection, iron sucrose, 1 mg <1% 1,292 $31K
82565 <1% 23,030 $31K
93976 <1% 216 $30K
77066 Tomosynthesis, mammo <1% 685 $30K
70551 Magnetic resonance imaging, brain; without contrast material <1% 182 $29K
86787 <1% 1,143 $29K
73562 <1% 1,622 $29K
83605 <1% 9,714 $29K
73630 <1% 1,620 $28K
36430 <1% 154 $27K
84153 <1% 1,735 $26K
81001 <1% 23,231 $26K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 15,391 $26K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 219 $26K
83690 <1% 24,302 $25K
74018 <1% 774 $25K
86901 <1% 5,450 $25K
82330 <1% 16,581 $24K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,931 $24K
93880 <1% 312 $24K
64415 <1% 107 $24K
72040 <1% 1,103 $24K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 987 $23K
97166 <1% 482 $22K
90791 Psychiatric diagnostic evaluation <1% 90 $22K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 5,657 $22K
87480 <1% 1,063 $21K
77065 Tomosynthesis, mammo <1% 526 $21K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,234 $21K
73130 <1% 1,040 $20K
87536 <1% 473 $20K
82746 <1% 2,783 $20K
73030 <1% 1,319 $20K
87641 <1% 507 $20K
85730 <1% 9,731 $19K
86480 <1% 490 $19K
96367 <1% 1,232 $19K
82950 <1% 1,773 $19K
77334 <1% 49 $19K
82043 <1% 3,394 $18K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 276 $18K
86003 <1% 571 $18K
84403 <1% 1,093 $18K
83020 <1% 904 $17K
75561 <1% 59 $17K
62321 <1% 38 $16K
87522 Neg quan hep c or qual rna <1% 585 $16K
94060 <1% 137 $16K
88341 <1% 310 $16K
84146 <1% 867 $15K
82670 <1% 532 $15K
77080 <1% 250 $15K
83001 <1% 884 $15K
73610 <1% 980 $14K
11043 <1% 45 $14K
29581 <1% 143 $14K
P9016 Red blood cells, leukocytes reduced, each unit <1% 132 $14K
C8908 Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral <1% 45 $14K
87070 <1% 1,718 $14K
96415 <1% 62 $14K
85652 <1% 4,164 $14K
86360 <1% 382 $14K
85380 <1% 3,445 $14K
86038 <1% 771 $14K
73501 <1% 602 $13K
87660 <1% 1,057 $13K
84132 <1% 22,831 $13K
82533 <1% 864 $13K
77336 <1% 92 $13K
76801 <1% 104 $13K
95886 <1% 61 $13K
74174 <1% 58 $12K
19083 <1% 16 $12K
97113 <1% 157 $12K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 504 $12K
84481 <1% 999 $12K
82947 <1% 21,165 $12K
84550 <1% 2,332 $12K
86704 <1% 968 $12K
96376 <1% 2,542 $12K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 976 $12K
87510 <1% 1,056 $11K
72070 <1% 399 $11K
84295 <1% 22,301 $11K
84156 <1% 2,976 $11K
86431 <1% 736 $11K
84520 <1% 20,823 $11K
97116 <1% 656 $11K
73110 <1% 588 $11K
86706 <1% 1,065 $11K
86160 <1% 449 $10K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 8,738 $10K
82435 <1% 20,535 $10K
C1769 Guide wire <1% 1,292 $9K
36591 <1% 1,551 $9K
84144 <1% 517 $9K
83615 <1% 1,945 $9K
82784 <1% 860 $9K
90715 <1% 591 $9K
86200 <1% 322 $9K
86800 <1% 373 $9K
80197 <1% 1,144 $8K
90686 <1% 483 $8K
97535 Self-care/home management training, each 15 minutes <1% 427 $8K
70498 <1% 188 $8K
86235 <1% 383 $8K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 366 $7K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 19,005 $7K
86359 <1% 379 $7K
86357 <1% 379 $7K
71101 <1% 432 $7K
86355 <1% 371 $7K
82550 <1% 1,303 $7K
76376 <1% 683 $7K
87186 <1% 1,506 $7K
82105 <1% 396 $7K
88185 <1% 71 $6K
83002 <1% 352 $6K
94729 <1% 120 $6K
74022 <1% 444 $6K
99213 Doctor's office visit, returning patient (routine) <1% 114 $6K
84100 <1% 2,986 $6K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 13 $6K
88342 <1% 673 $6K
87147 <1% 1,219 $6K
84480 <1% 519 $6K
84165 <1% 599 $5K
93926 <1% 99 $5K
86225 <1% 297 $5K
86665 <1% 476 $5K
94726 <1% 103 $5K
84134 <1% 715 $5K
11045 <1% 17 $5K
73502 <1% 468 $5K
64493 <1% 16 $5K
87205 <1% 1,278 $5K
83516 <1% 172 $5K
97163 <1% 75 $4K
J2800 Injection, methocarbamol, up to 10 ml <1% 1,378 $4K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 15 $4K
83525 <1% 259 $4K
72197 <1% 15 $4K
73560 <1% 454 $4K
88304 <1% 536 $4K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 7,731 $4K
0002A <1% 565 $4K
74183 <1% 12 $4K
00400 <1% 42 $4K
82785 <1% 221 $4K
86592 <1% 396 $4K
93750 <1% 738 $4K
C9145 Injection, aprepitant, (aponvie), 1 mg <1% 90 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 9,299 $4K
12001 <1% 26 $4K
83521 <1% 577 $4K
87040 <1% 2,055 $4K
0001A <1% 579 $3K
73590 <1% 381 $3K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,285 $3K
87210 <1% 3,408 $3K
82627 <1% 222 $3K
82378 <1% 293 $3K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,703 $3K
82040 <1% 445 $3K
86696 <1% 148 $3K
83721 <1% 196 $3K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 180 $3K
85018 <1% 976 $3K
88184 <1% 64 $3K
73140 <1% 155 $3K
93321 <1% 348 $3K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 424 $3K
G0008 Administration of influenza virus vaccine <1% 1,131 $3K
85384 <1% 841 $3K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 1,039 $3K
C1760 Closure device, vascular (implantable/insertable) <1% 252 $3K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,236 $3K
87081 <1% 208 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,343 $3K
86709 <1% 239 $3K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 139 $3K
82150 <1% 3,924 $2K
A9585 Injection, gadobutrol, 0.1 ml <1% 1,445 $2K
82803 <1% 1,242 $2K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,206 $2K
84155 <1% 452 $2K
84238 <1% 137 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 5,541 $2K
88302 <1% 154 $2K
00731 <1% 386 $2K
84145 <1% 594 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,991 $2K
01402 <1% 28 $2K
86334 <1% 153 $2K
86705 <1% 168 $2K
73070 <1% 87 $2K
86664 <1% 214 $2K
97012 <1% 59 $2K
J1644 Injection, heparin sodium, per 1000 units <1% 3,909 $2K
86147 <1% 32 $2K
85014 <1% 650 $1K
01214 <1% 20 $1K
86593 <1% 107 $1K
73700 <1% 12 $1K
82951 <1% 77 $1K
81015 <1% 606 $1K
73620 <1% 41 $1K
86923 <1% 48 $1K
76870 <1% 33 $1K
82805 <1% 26 $1K
86695 <1% 98 $1K
86880 <1% 85 $1K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,325 $1K
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 2,779 $954.77
84436 <1% 255 $943.25
80320 <1% 101 $909.11
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 124 $868.54
86870 <1% 22 $868.16
85046 <1% 300 $861.47
87497 <1% 135 $851.88
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,633 $843.63
83051 <1% 31 $800.87
82010 <1% 847 $773.28
20561 <1% 27 $748.14
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,008 $722.32
J2785 Injection, regadenoson, 0.1 mg <1% 494 $704.16
84703 <1% 468 $701.99
81374 <1% 17 $672.28
J3370 Injection, vancomycin hcl, 500 mg <1% 760 $670.63
85347 <1% 697 $659.56
J2550 Injection, promethazine hcl, up to 50 mg <1% 1,535 $646.11
86146 <1% 32 $635.86
82140 <1% 167 $621.96
94761 <1% 575 $612.42
11721 <1% 27 $588.01
83520 <1% 21 $572.63
88112 <1% 37 $568.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 502 $567.63
87529 <1% 19 $561.42
97016 <1% 20 $551.08
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,777 $550.51
83010 <1% 63 $532.25
00910 <1% 57 $514.99
87075 <1% 83 $506.86
99214 Doctor's office visit, returning patient (more involved) <1% 15 $502.62
86812 <1% 52 $502.33
86304 <1% 83 $471.35
84402 <1% 16 $441.04
76937 <1% 166 $440.32
86300 <1% 30 $440.10
86708 <1% 14 $431.83
Q3014 Telehealth originating site facility fee <1% 71 $430.26
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 947 $429.17
73552 <1% 32 $418.24
86231 <1% 48 $388.14
83695 <1% 39 $387.55
86364 <1% 32 $359.53
J3475 Injection, magnesium sulfate, per 500 mg <1% 657 $347.07
90656 <1% 38 $338.84
J0360 Injection, hydralazine hcl, up to 20 mg <1% 540 $336.37
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,015 $336.34
82952 <1% 47 $334.89
86039 <1% 16 $323.32
90653 <1% 26 $320.39
J1956 Injection, levofloxacin, 250 mg <1% 266 $316.56
80171 <1% 17 $304.06
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 152 $295.27
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 1,107 $283.20
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 444 $280.14
J1940 Injection, furosemide, up to 20 mg <1% 703 $280.10
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 488 $270.32
J2060 Injection, lorazepam, 2 mg <1% 884 $253.41
76942 <1% 34 $241.40
00811 <1% 61 $238.75
82810 <1% 205 $236.68
00952 <1% 28 $236.54
96402 <1% 13 $198.70
J0780 Injection, prochlorperazine, up to 10 mg <1% 966 $193.37
87015 <1% 129 $190.23
90662 <1% 26 $179.56
80143 <1% 67 $168.43
72170 <1% 15 $162.60
85004 <1% 21 $151.93
J1790 Injection, droperidol, up to 5 mg <1% 859 $143.89
J3480 Injection, potassium chloride, per 2 meq <1% 349 $142.61
87206 <1% 88 $141.81
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 63 $128.71
J1650 Injection, enoxaparin sodium, 10 mg <1% 173 $126.21
87799 <1% 151 $125.44
88173 <1% 18 $121.04
84460 <1% 13 $111.58
73090 <1% 20 $111.34
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 56 $104.88
88300 <1% 12 $103.85
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 385 $102.03
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 54 $88.21
Q0114 Fern test <1% 43 $87.91
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 865 $81.25
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 321 $80.07
73060 <1% 14 $79.91
88738 <1% 20 $76.29
J1626 Injection, granisetron hydrochloride, 100 mcg <1% 692 $75.81
G0009 Administration of pneumococcal vaccine <1% 15 $70.27
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 34 $56.89
J1171 Injection, hydromorphone, 0.1 mg <1% 138 $54.61
C1819 Surgical tissue localization and excision device (implantable) <1% 31 $39.73
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 53 $39.39
80181 <1% 24 $19.57
82272 <1% 20 $8.80
00812 0% 17 $0.00
91300 0% 273 $0.00
77001 0% 96 $0.00
00790 0% 15 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 16 $0.00
72072 0% 13 $0.00
J0500 Injection, dicyclomine hcl, up to 20 mg 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHERPENBERG, THEODORE (CFO)
Parent organizationCHRIST HOSPITAL